Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
Clinical trial NCT03392896 · COMPLETED
Trial details
- NCT number
- NCT03392896
- Sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-11-19
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.